MEN1
Also known as: Multiple Endocrine Neoplasia Type 1 / Multiple Endocrine Neoplasia, Type 1 / Multiple endocrine neoplasia [MEN] type I / MEA Type I / Multiple endocrine neoplasia Type I / MEN Type I / Multiple endocrine adenomatosis Type I / Multiple endocrine neoplasia, type 1 (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17969 | Edotreotide | 0 | Terminated | 1 |
| DB15494 | Edotreotide gallium Ga-68 | 0 | Terminated | 1 |
| DB01101 | Capecitabine | 1 | Withdrawn | 1 |
| DB00853 | Temozolomide | 1 | Withdrawn | 1 |
| DB07232 | Veliparib | 1 | Withdrawn | 1 |
| DB08885 | Aflibercept | 2 | Completed | 1 |
| DB13925 | Dotatate gallium Ga-68 | 2 | Completed | 1 |
| DB01590 | Everolimus | 2 | Active Not Recruiting | 1 |
| DB09078 | Lenvatinib | 2 | Active Not Recruiting | 1 |
| DB06589 | Pazopanib | 2 | Completed | 1 |